
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check outpatient management of the nephritic syndrome, the biopsy criteria, the Jones criteria assessment of the joint pains, and the decision not to test for strep at the cold. | ||
| provenance review | not_started | Wien Geschichte Wiki pages (City of Vienna), the 1882 English translation of Jahn's biography (Project Gutenberg), and PubMed abstracts logged. The cause of death is not documented; every proposed cause is graded R, and the poisoning legend is marked unsupported. | ||
| safe messaging review | not_started | No behavioral-health content beyond a negative depression screen. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-09-29 Progress note 03 (C-CDA) | Creatinine with eGFR, BUN, and potassium, one week after the consultation | About weekly while creatinine is raised or on a diuretic | Protocol deviation: the check planned for about a week after the consultation, while creatinine was still rising on furosemide, was not drawn because he missed the laboratory appointment. Judging by today's results (creatinine falling to 1.05 mg/dL, potassium 4.3 mmol/L) no harm resulted. Corrective action: blood tests are now booked for the morning of each visit, and he was asked to call if he cannot attend |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-10-13 Progress note 04 (C-CDA) | Prevention | HIV screening | Ordered | One-time screening for adults 15 to 65; antigen-antibody test drawn today with his agreement |
| 2026-10-13 Progress note 04 (C-CDA) | Prevention | Hepatitis C screening | Ordered | One-time antibody test for adults 18 to 79, drawn today |
| 2026-10-13 Progress note 04 (C-CDA) | Prevention | Hepatitis B screening | Ordered | One-time triple panel (surface antigen, surface antibody, and core antibody) drawn today; vaccination to follow if he is not immune |
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0014 | A 2009 study of the official Vienna death register for November 1791 to January 1792 and the same months of the years before and after found that deaths from edema were markedly increased among younger men in the weeks around his death, a minor epidemic that may have begun in the military hospital; the authors concluded that their analysis is consistent with his last illness being a streptococcal infection leading to an acute nephritic syndrome from post-streptococcal glomerulonephritis, with scarlet fever less likely. | possible |
| CLM-0015 | One author argues that he had frequent attacks of tonsillitis throughout his life and that in 1784 he developed a post-streptococcal Schönlein-Henoch syndrome. | disputed |
| CLM-0016 | The same author proposes that the 1784 illness caused chronic glomerulonephritis and chronic kidney failure, that the fatal illness was Schönlein-Henoch purpura with death from cerebral hemorrhage and bronchopneumonia, and that bloodletting may have contributed to his death. | disputed |
| CLM-0017 | Many other causes of his final illness have been proposed, including kidney failure and trichinosis (argued in a 2001 review titled "What killed Mozart?"), and none has been established. | disputed |
| CLM-0018 | In his last weeks he told his wife that he believed he had been poisoned, and rumors of poisoning circulated after his death, including a later accusation against Antonio Salieri. His nineteenth-century biographer calls the accusation a calumny, rebutted at the time by Carpani and Neukomm; no evidence supports poisoning. | disputed |
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-09-15 | BUN | 31 mg/dL (high) | High |
| 2026-09-15 | Creatinine | 1.62 mg/dL (high) | High |
| 2026-09-15 | CRP | 18 mg/L (high) | High |
| 2026-09-15 | ESR | 38 mm/h (high) | High |
| 2026-09-15 | C3 | 42 mg/dL (low) | Low |
| 2026-09-15 | ASO | 620 [IU]/mL (high) | High |
| 2026-09-15 | Anti-DNase B | 980 [IU]/mL (high) | High |
| 2026-09-15 | Urine red cells | 60 /[HPF] (high) | High |
| 2026-09-15 | Urine protein-to-creatinine ratio | 1400 mg/g (high) | High |
| 2026-09-15 | eGFR | 59 mL/min/1.73 m² (low) | Low |
| 2026-09-17 | BUN | 34 mg/dL (high) | High |
| 2026-09-17 | Creatinine | 1.78 mg/dL (high) | High |
| 2026-09-17 | Urine red cells | 45 /[HPF] (high) | High |
| 2026-09-17 | Urine protein-to-creatinine ratio | 1100 mg/g (high) | High |
| 2026-09-17 | eGFR | 53 mL/min/1.73 m² (low) | Low |
| 2026-09-29 | C3 | 74 mg/dL (low) | Low |
| 2026-09-29 | Urine red cells | 25 /[HPF] (high) | High |
| 2026-09-29 | Urine protein-to-creatinine ratio | 420 mg/g (high) | High |
| 2026-10-27 | Urine red cells | 8 /[HPF] (high) | High |
| 2026-10-27 | Urine protein-to-creatinine ratio | 180 mg/g (high) | High |
| 2026-10-22 | Urine red cells | 12 /[HPF] (high) | High |